Week in Review: September 30–October 4

Scientists feel the shutdown’s sting; dogs comprehend human cues; lab-grown secretory glands; whether online comments help or hurt science

Written byTracy Vence
| 5 min read

Register for free to listen to this article
Listen with Speechify
0:00
5:00
Share

WIKIMEDIA, U.S. DEPARTMENT OF THE TREASURYReacting to furloughs and other cutbacks enacted with the US government shutdown that began this week (October 1), federally funded researchers expressed concerns over obtaining new grants and sustaining their current programs. Federal science agencies including the National Institutes of Health (NIH) and the National Science Foundation (NSF) are left unable to process grant proposals while Congress continues its budget debates, and have asked applicants to hold onto their materials for later submission.

“We have a grant that is currently awaiting review—the panel is scheduled to meet October 21,” Michigan State University’s Robert Britton told The Scientist. “So that will likely be delayed.”

Longer term, academic researchers are concerned about the doubly harmful effects that both federal budget sequestration and the current government shutdown could have on the careers of junior scientists. “Funding has always been cyclical and hopefully will turn around soon, but it is getting harder to look people in the eye and tell them there will be a decent job waiting for them at the end of their training,” said Britton.

Timothy Girard, an assistant professor at the Vanderbilt University School of Medicine, echoed Britton’s worry, noting the significant challenges of finding funding. “The bottom ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies